FDA is Advancing the Goals of the Orphan Drug Act

By: Scott Gottlieb, M.D. Three months ago, I committed to fully eliminate a backlog of about 200 orphan drug designation requests that were pending review with FDA, and to implement policies that would require FDA to respond to all new … Continue reading →

Source: FDA Voice - September 12, 2017 Category: American Health Source Type: blogs